<p>Top panel shows mean ± SEM coherence of all 23 subjects in the off (blue) and on (red) medication state. Bottom panel shows the mean ± SEM % change between the two states (on –off medication) in the beta sub-bands. Only the coherence suppression in the beta 1 band following levodopa was significant (t22 = −2.7; p = 0.01).</p
<p>SPM-based analyses across all sensors and time-points revealed main effects of drug group (levodo...
<p>Individual coherence spectra obtained in each condition for the right-hemisphere MEG sensor showi...
<p>Histogram of all phase differences across 23 subjects at peak beta frequency off medication, demo...
<p>Top panel shows mean ± SEM amplitude co-modulation of all 23 subjects in the off (blue) and on (r...
<p>Top panel shows mean ± SEM amplitude PLV of all 23 subjects in the off (blue) and on (red) medica...
<p>Each point relates to a frequency bin in the 15.3–32.2 Hz range in individual muscles and subject...
<p>(A) alpha (8–12 Hz) band. (B) beta (13–30 Hz) band. (C) gamma (31–50 Hz) band. In each frequency ...
<p>For all panels data was averaged over 10 trials, the error bars or shaded areas represent the sta...
<p>The arrows mark the peak maxima (A). Mean M1-SMA coherence strength in GTS-patients (black) and h...
<p>The most left graphs (A,E,I) depict the coherence spectra within the 15–35 Hz frequency range for...
<p>Average coherence spectra are shown for MG-EDB and TA-EDB in the lower limb (A,C) and for EDC-FDI...
Objective: To better understand the mechanism of action of anti-dystonia medications by comparing ce...
<p>(A) Coherence spectra during RS1 (black), after in-phase stimulation (RS3, green), and after anti...
<p>Participants in the drowsy group had relatively lower small-worldness (A) already at baseline. Me...
<p>In the left panel, the intertrial coherence irrespective of condition is depicted. While a strong...
<p>SPM-based analyses across all sensors and time-points revealed main effects of drug group (levodo...
<p>Individual coherence spectra obtained in each condition for the right-hemisphere MEG sensor showi...
<p>Histogram of all phase differences across 23 subjects at peak beta frequency off medication, demo...
<p>Top panel shows mean ± SEM amplitude co-modulation of all 23 subjects in the off (blue) and on (r...
<p>Top panel shows mean ± SEM amplitude PLV of all 23 subjects in the off (blue) and on (red) medica...
<p>Each point relates to a frequency bin in the 15.3–32.2 Hz range in individual muscles and subject...
<p>(A) alpha (8–12 Hz) band. (B) beta (13–30 Hz) band. (C) gamma (31–50 Hz) band. In each frequency ...
<p>For all panels data was averaged over 10 trials, the error bars or shaded areas represent the sta...
<p>The arrows mark the peak maxima (A). Mean M1-SMA coherence strength in GTS-patients (black) and h...
<p>The most left graphs (A,E,I) depict the coherence spectra within the 15–35 Hz frequency range for...
<p>Average coherence spectra are shown for MG-EDB and TA-EDB in the lower limb (A,C) and for EDC-FDI...
Objective: To better understand the mechanism of action of anti-dystonia medications by comparing ce...
<p>(A) Coherence spectra during RS1 (black), after in-phase stimulation (RS3, green), and after anti...
<p>Participants in the drowsy group had relatively lower small-worldness (A) already at baseline. Me...
<p>In the left panel, the intertrial coherence irrespective of condition is depicted. While a strong...
<p>SPM-based analyses across all sensors and time-points revealed main effects of drug group (levodo...
<p>Individual coherence spectra obtained in each condition for the right-hemisphere MEG sensor showi...
<p>Histogram of all phase differences across 23 subjects at peak beta frequency off medication, demo...